TickerFactsScreenerDevelopers

Amneal Pharmaceuticals, Inc. (AMRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $27.37M2017: $74.17M2018: $213.39M2019: $151.20M2020: $341.38M2021: $247.79M2022: $25.98M2023: $91.54M2024: $110.55M2025: $282.03M$282.03M
2016Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$282.03M+155.1%
2024$110.55M+20.8%
2023$91.54M+252.4%
2022$25.98M-89.5%
2021$247.79M-27.4%
2020$341.38M+125.8%
2019$151.20M-29.1%
2018$213.39M+187.7%
2017$74.17M+171.0%
2016$27.37M—